Trademark: AFFIMED 2331458
Word
AFFIMED
Device Descrption:
CELL IN MOLECULAR-DIAGRAM
ID
2331458
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
13 September 2022
Registration Date
13 September 2022
Renewal Date
13 September 2032
Owner(s)
Service
Goods and Services:
Class 1:
Biological and biochemical preparations for medical purposes in form of bifunctional or multifunctional proteins with binding affinity to immune cells, antibodies, antibody derivatives, binding proteins and peptides for laboratory and experimentation purposes, in particular for conducting experimental assays (other than for medical or veterinary purposes).
Biological and biochemical preparations for medical purposes in form of bifunctional or multifunctional proteins with binding affinity to immune cells, antibodies, antibody derivatives, binding proteins and peptides for laboratory and experimentation purposes, in particular for conducting experimental assays (other than for medical or veterinary purposes).
Class 5:
Pharmaceutical and veterinary preparations; biological and biochemical preparations for medical purposes in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes; biological and biochemical preparations for medical purposes in form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays.
Pharmaceutical and veterinary preparations; biological and biochemical preparations for medical purposes in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes; biological and biochemical preparations for medical purposes in form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays.
Class 42:
Scientific and technological services, research and design in the field of immunotherapy, in particular in the field of immuno-oncology; scientific and technological services, research and design in the field of virology; scientific and technological services, research and design in the field of antiinfectives; scientific and technological services, research and design in the field of neurodegenerative diseases; scientific and technological services, research and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services, research and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial analysis and research services.
Scientific and technological services, research and design in the field of immunotherapy, in particular in the field of immuno-oncology; scientific and technological services, research and design in the field of virology; scientific and technological services, research and design in the field of antiinfectives; scientific and technological services, research and design in the field of neurodegenerative diseases; scientific and technological services, research and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services, research and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial analysis and research services.